Navigation Links
MedTrust Online Surpasses 5,000 Registered Users and Adds Dr. Henry Friedman to Oncology Advisory Board
Date:9/17/2009

SCOTTSDALE, Ariz., Sept. 17 /PRNewswire/ -- MedTrust Online, a world-leading provider of clinically-useful knowledge for oncologists seeking therapy options for challenging patient cancer cases, has surpassed 5,000 registered users on its free portal, Oncocentric.com. MedTrust Online also announced today that world-renowned oncologist Dr. Henry Friedman has joined MedTrust Online's growing board of oncology advisors.

"5,000 users is concrete validation that our portal can answer the critical need of oncologists for the latest medical knowledge," stated President and CEO Chris Yoo, Ph.D. "And we are honored to have Dr. Friedman join our illustrious oncology advisory board. The rapid growth in our network of users is a direct result of having the top experts available to help practicing oncologists every day through our portal."

With the addition of Dr. Henry Friedman, Deputy Director of The Preston Robert Tisch Brain Tumor Center at Duke, MedTrust Online continues to attract the brightest minds in new therapeutics and world-renowned cancer care experts.

"I personally believe that targeted personalized therapy is the wave of the future and should be accessible to everyone," stated Dr. Friedman. "I am excited to join MedTrust Online and contribute to making that statement not only a possibility, but a reality."

MedTrust Online also announced a contract with Prometheus Laboratories, another leader in the promising group of companies offering molecular diagnostics in oncology.

"We are pleased to add Prometheus Laboratories as a new content provider to our portal," said Chief Business Officer Russell Clark. "Each new molecular diagnostics customer adds important content that helps our oncologists identify the most appropriate diagnostic and therapeutic options for their patients and provides our customers with important new channels into the oncology market."

About MedTrust Online:

Founded by leaders of the Translational Genomics Research Institute (TGen), MedTrust Online (MTOL) helps cancer doctors practice the most precise medicine for their patients by providing best practice knowledge about the most difficult cases. Through the portal, www.oncocentric.com, any oncologist can find important diagnostic and treatment information and communicate with experts about the best options for individualized therapy. MTOL brings together experts in Oncology, information technology, computational biology, pharmaceutical drug development, and personalized medicine to integrate and present the latest in cutting-edge cancer care. This knowledge is presented as a free resource to doctors in a comprehensive yet concise way unavailable anywhere else.


'/>"/>
SOURCE MedTrust Online
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Exiqon Diagnostics Partners With MedTrust Online to Promote KRAS Mutation Analysis and Other Innovative Molecular Oncology Diagnostic Services to Oncologists
2. MedTrust Online and Scottsdale Clinical Research Institute at Scottsdale Healthcare Announce Collaboration to Provide Cutting Edge Technology to Improve Patient Care
3. Oncologists Visit Pharma Sites and Post Professional Content Online More Frequently than the Average Physician
4. Inspiring New Online Destination From Bayer Diabetes Care
5. Video: New Way RA(TM) Talk Show Premieres Online for People Living With Rheumatoid Arthritis (RA)
6. New and Updated Online Tutorials for dbGaP, GAD, and DGV from OpenHelix
7. MSNBC Publishes Free Online Abridgment of Biocentrism
8. Elsevier / MC Strategies Online Courses Named in the 15th Annual Communicator Awards
9. Drug Information Association Launches New 45th Annual Meeting Online
10. New Online Tutorial for DAVID
11. PharmSource Adds New Capabilities to the PharmSource ADVANTAGE Online Service
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... April 27, 2016 , ... ... its Scientific Advisory Board. Dr. Lamka will assist PathSensors in expanding the use ... , PathSensors deploys the CANARY® test platform for the detection of harmful pathogens, ...
(Date:4/27/2016)... MedDay, a biotechnology company focused on ... of Catherine Moukheibir as Chairman of its Board of Directors. ... Jacques Garaud , who contributed to the rapid development of ... Catherine started her career in strategy consulting and investment ... London .  She held C-Suite level roles in some ...
(Date:4/26/2016)... ... ... The European Patent Office (EPO) today announced that U.S. Biophysicist ... Inventor Award 2016 in the category "Non-European countries." The winners of the 11th edition ... on June 9th. , The human capacity to walk with fluidity is the sum ...
(Date:4/26/2016)... , ... April 26, 2016 , ... BioFactura, Inc ... Series A round of financing. Healthy investor interest drove significant oversubscription of the ... generic biologics, known as biosimilars, to the advanced preclinical stages. , Chief Executive Officer ...
Breaking Biology Technology:
(Date:3/10/2016)... , March 10, 2016 ... new market research report "Identity and Access Management Market ... Audit, Compliance, and Governance), by Organization Size, by Deployment, ... 2020", published by MarketsandMarkets, The market is estimated to ... 12.78 Billion by 2020, at a Compound Annual Growth ...
(Date:3/8/2016)... , March 8, 2016   Valencell , ... today announced it has secured $11M in Series ... Tech, a new venture fund being launched by ... participation from existing investors TDF Ventures and WSJ ... to continue its triple-digit growth and accelerate its ...
(Date:3/2/2016)... March 2, 2016 ... the "Global Biometrics as a Service ... --> http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) has ... Biometrics as a Service Market 2016-2020" ... Research and Markets ( http://www.researchandmarkets.com/research/cmt3hk/global_biometrics ) ...
Breaking Biology News(10 mins):